Patient Leaflet Updated 21-Jul-2023 | Bayer plc
Kerendia 10 mg film coated tablets
Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes.
If you have any doubts or queries about your medication, please contact your doctor or pharmacist.
Kerendia 10 mg film-coated tablets
Kerendia 20 mg film-coated tablets
finerenone
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What Kerendia is and what it is used for
2. What you need to know before you take Kerendia
3. How to take Kerendia
4. Possible side effects
5. How to store Kerendia
6. Contents of the pack and other information
Kerendia contains the active substance finerenone. Finerenone works by blocking the action of certain hormones (mineralocorticoids) that can damage your kidneys and heart.
Kerendia is used for the treatment of adults with chronic kidney disease (stage 3 and 4 with abnormal presence of the protein albumin in the urine) associated with type 2 diabetes.
Chronic kidney disease is a long-term condition. Your kidneys keep getting worse at removing waste and fluids from your blood.
Type 2 diabetes is when your body cannot keep your blood sugar levels normal. Your body does not produce enough of the hormone insulin or cannot use the insulin properly. This leads to a high level of sugar in your blood.
Talk to your doctor or pharmacist before taking Kerendia if you have
Blood tests
These tests check your potassium level and how your kidneys are working.
Using the results of your blood tests, your doctor decides whether you can start to take Kerendia.
After 4 weeks of taking Kerendia, you will have more blood tests.
Your doctor may test your blood at other times, for example while you are taking certain medicines.
Do not give this medicine to children and adolescents under 18 years because it is not known yet whether it is safe and effective in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Your doctor will tell you which medicines you can take. Your doctor may need to test your blood to make sure.
You must not take medicines that belong to the group of ‘strong CYP3A4 inhibitors,’ while taking Kerendia (see section 2 “Do not take Kerendia…”).
Talk to your doctor or pharmacist if you are taking other medicines while taking Kerendia, especially
Do not eat grapefruit or drink grapefruit juice as long as you take Kerendia.
If you do, you may get too much finerenone in your blood. You may have more side effects (possible side effects are listed in section 4).
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
You should not take this medicine during pregnancy unless your doctor states it is clearly necessary. There might be a risk to your unborn baby. Your doctor will discuss that with you.
You should use reliable birth control if you are able to become pregnant. Your doctor will explain to you what type of birth control you can use.
Breast-feeding
You should not breast-feed while taking this medicine. It may harm your baby.
Kerendia has no effect on your ability to drive or use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended and the maximum daily dose of this medicine is 1 tablet of 20 mg.
Your doctor may decide on changes in your treatment after testing your blood. See “Blood tests” in section 2 for more information.
Kerendia is taken by mouth. Take Kerendia at the same time every day. This makes it easier for you to remember.
Swallow the tablet whole.
If you cannot swallow the tablet whole, you can crush it.
Talk to your doctor or pharmacist if you think you have taken too much of this medicine.
If you forget to take your tablet at your regular time that day
If you miss a day
Do not take 2 tablets to make up for a forgotten tablet.
Only stop taking Kerendia if your doctor has told you.
Your doctor may decide this after testing your blood.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects that your doctor may see in your blood test results
very common (may affect more than 1 in 10 people)
common (may affect up to 1 in 10 people)
uncommon (may affect up to 1 in 100 people)
common (may affect up to 1 in 10 people)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister, bottle label and carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Kerendia 10 mg film-coated tablets (tablets) are pink and oval-oblong, 10 mm long and 5 mm wide, marked ‘10’ on one side and ‘FI’ on the other side.
Kerendia 20 mg film-coated tablets (tablets) are yellow and oval-oblong, 10 mm long and a 5 mm wide, marked ‘20’ on one side and ‘FI’ on the other side.
Kerendia is available in cartons containing
Not all pack sizes may be marketed.
For any information about this medicine, please contact:
This leaflet was last revised in 07/2023.
GB v003_0
400 South Oak Way, Reading, Berkshire, RG2 6AD
+44 (0)118 206 3000